non-small cell lung cancer
Conditions
Brief summary
PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by Investigator. OS is defined as time from randomization until death from any cause.
Interventions
DRUGDOCETAXEL
Sponsors
Revolution Medicines Inc.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS is defined as time from randomization until disease progression or death from any cause, whichever occurs first. Progression is per RECIST v1.1 as assessed by Investigator. OS is defined as time from randomization until death from any cause. | — |
Countries
Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Spain
Outcome results
None listed